Hyundai Mobis, the South Korean auto parts giant, began prototype production in November 2026 of actuators for Boston Dynamics' Atlas humanoid robot at its Uiwang research center in Gyeonggi Province, with full-scale supply targeted for 2028. The move came alongside third-quarter earnings that showed operating profit of 914.1 billion won, roughly $684.7 million, up 17.2% year over year, according to a report cited by BigGo Finance.
The company expects to eventually supply all 31 actuators used in a single Atlas unit. It is planning a U.S. manufacturing facility with annual capacity of 350,000 units, expandable to 700,000 with a second shift, timed to come online alongside Atlas's 2028 commercial rollout at Hyundai Motor Group's Georgia plant. Hyundai Mobis is also developing hand grippers, perception modules and controllers, pushing beyond actuators into a broader slice of the humanoid component stack.
Why an auto-parts supplier wants into robotics
Actuators function as the muscles and joints of a humanoid robot, and Hyundai Mobis says they account for 40% to 60% of a humanoid's total manufacturing cost, by far the most expensive category of components. For a company built on decades of supplying precision automotive parts at automotive-scale volumes, that cost concentration looks like an opening: whoever can mass-produce reliable actuators cheaply controls the economics of the entire humanoid industry, the same way engine and battery suppliers shape margins in cars.
Hyundai Mobis has backed that bet with internal reorganization. The company created a dedicated robotics components unit and roughly doubled its headcount in that division. Annual R&D spending is set to exceed 2 trillion won, about $1.5 billion, for the first time this year. Company representatives have described the strategy in blunt terms: continuously improving performance through product standardization and modularization, the same playbook that let automotive suppliers scale from prototype to millions of units a year.
The competitive stakes of owning the humanoid supply chain
Hyundai's position is unusual because its parent group, Hyundai Motor, also owns Boston Dynamics outright, giving Hyundai Mobis a captive first customer and a multi-year head start on component specifications most rivals cannot see yet. That is a sharp contrast with China's humanoid supply chain, where dozens of component makers compete to supply AgiBot, Unitree and UBTech on an arm's-length basis, often at thinner margins.
But a captive customer is not the same as a guaranteed market. Hyundai Mobis's stated ambition is to attract additional humanoid manufacturers as customers beyond Atlas, a goal that puts it in direct competition with established robotics suppliers and with Chinese actuator makers racing to cut costs at scale. The company's order book gives an early read on how that is going: core-component orders year-to-date have reached 12.8% of its annual $8.974 billion target, with North American orders at 9% of a $5.794 billion target, and total projected orders for the year expected to exceed plan by 18.3%. Whether that momentum holds depends heavily on whether Atlas itself hits its 2028 commercial deployment target, since Hyundai Mobis's biggest bet is still tied to a single robot that has not yet shipped at scale.